Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Heart FailureAnemiaIron Deficiency
Interventions
DRUG

Ferric Carboxymaltose

1000mg intravenous Ferric Carboxymaltose, given as undiluted slow bolus injection over 15 minutes. Allowed to take concomitant oral iron supplements in usual clinical doses as prescribed clinically by attending physicians.

DRUG

Placebo

20mls intravenous Normal Saline (0.9%), given as slow bolus injection over 15 minutes. Allowed to take concomitant oral iron supplements in usual clinical doses as prescribed clinically by attending physicians.

Trial Locations (2)

119074

National University Heart Centre, Singapore, Singapore

308433

Tan Tock Seng Hospital, Singapore

All Listed Sponsors
collaborator

National University Heart Centre, Singapore

OTHER

collaborator

Tan Tock Seng Hospital

OTHER

lead

National University Hospital, Singapore

OTHER

NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure | Biotech Hunter | Biotech Hunter